-
Mashup Score: 1EMA Grants PRIME Designation to NX-5948 for R/R CLL/SLL - 20 hour(s) ago
NX-5948 has received PRIME designation from the EMA for the treatment of relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 30FDA Lifts Partial Clinical Hold on Trial Evaluating NX-2127 in R/R B-Cell Malignancies - 9 month(s) ago
The FDA has lifted a partial clinical hold on a phase 1 trial evaluating NX-2127 in relapsed/refractory B-cell malignancies
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
FDA Lifts Partial Clinical Hold on Trial Evaluating NX-2127 in R/R B-Cell Malignancies #lymsm #leusm #Oncology https://t.co/b3sawCokGj
-
-
Mashup Score: 9FDA Lifts Partial Clinical Hold on Trial Evaluating NX-2127 in R/R B-Cell Malignancies - 9 month(s) ago
The FDA has lifted a partial clinical hold on a phase 1 trial evaluating NX-2127 in relapsed/refractory B-cell malignancies
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
FDA Lifts Partial Clinical Hold on Trial Evaluating NX-2127 in R/R B-Cell Malignancies #lymsm #leusm #Oncology https://t.co/b3sawCokGj
-
-
Mashup Score: 3FDA Places Partial Clinical Hold on Phase 1 Trial of NX-2127 in R/R B-Cell Malignancies - 1 year(s) ago
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
FDA Places Partial Clinical Hold on Phase 1 Trial of NX-2127 in R/R B-Cell Malignancies #lymsm #leusm #oncology https://t.co/uZh0dTYrYe
-
-
Mashup Score: 3FDA Places Partial Clinical Hold on Phase 1 Trial of NX-2127 in R/R B-Cell Malignancies - 1 year(s) ago
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
FDA Places Partial Clinical Hold on Phase 1 Trial of NX-2127 in R/R B-Cell Malignancies #lymsm #leusm #oncology https://t.co/uZh0dTYrYe
-
-
Mashup Score: 3FDA Places Partial Clinical Hold on Phase 1 Trial of NX-2127 in R/R B-Cell Malignancies - 1 year(s) ago
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
FDA Places Partial Clinical Hold on Phase 1 Trial of NX-2127 in R/R B-Cell Malignancies #lymsm #leusm #oncology https://t.co/uZh0dTYrYe
-
EMA Grants PRIME Designation to NX-5948 for R/R CLL/SLL #lymsm #leusm #oncology https://t.co/ybO1lGHDkH